Log in
Enquire now
‌

US Patent 9422310 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Patent 9422310 was granted and assigned to Neurocrine Biosciences on August, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Neurocrine Biosciences
Neurocrine Biosciences
Current Assignee
Neurocrine Biosciences
Neurocrine Biosciences
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9422310
Date of Patent
August 23, 2016
Patent Application Number
14592690
Date Filed
January 8, 2015
Patent Citations Received
‌
US Patent 11957684 Treatment of heavy menstrual bleeding associated with uterine fibroids
0
‌
US Patent 11713324 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
0
‌
US Patent 11918583 Treatment of heavy menstrual bleeding associated with uterine fibroids
0
Patent Primary Examiner
‌
Nizal Chandrakumar
Patent abstract

GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9422310 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.